We retrospectively reviewed the clinical characteristics and outcomes of 61 patients with 62 episodes of prosthetic valve endocarditis, paying particular attention to neurologic complications (stroke). Atypical features of the group included a benign outcome of early postoperative infection (18% mortality) and a high stroke morbidity and mortality rate with Staphylococcus epidermidis infections. Eleven patients (18%) suffered an embolic stroke, most <3 days after diagnosis and before the initiation of antimicrobial therapy; the rate of embolic stroke recurrence was low (9%). The risk of embolic stroke was lower with bioprosthetic than with mechanical valves. No protective effect of anticoagulation therapy with warfarin was observed. Six patients (8%) suffered brain hemorrhage due to septic arteritis, brain infarction, or undetermined causes; no specific risk of hemorrhagic stroke was evident with anticoagulation therapy. Antibiotic treatment appears to be more important than anticoagulation to prevent neurologic complications in patients with prosthetic valve endocarditis. {Stroke 1990;21:993-999) T he management of patients with prosthetic valve endocarditis has been controversial, with the neurologic sequelae of embolic stroke and cerebral hemorrhage being particularly salient issues. Many studies have reported embolic stroke rates of 25-60% in patients not receiving anticoagulation therapy as part of their medical regimen.
T he management of patients with prosthetic
valve endocarditis has been controversial, with the neurologic sequelae of embolic stroke and cerebral hemorrhage being particularly salient issues. Many studies have reported embolic stroke rates of 25-60% in patients not receiving anticoagulation therapy as part of their medical regimen. 1^3 Other anecdotal reports 4 and reviews 5 have emphasized the risk of cerebral hemorrhage. Despite the increasing use of heterograft bioprostheses over the past 2 decades, specific treatment and neurologic outcomes of these patients have not been systematically reported. 6 -11 We analyzed 62 episodes of prosthetic valve endocarditis in 61 patients, paying special attention to predictors of embolic stroke and brain hemorrhage. Our data emphasize the heterogeneous nature of the patient population and the practical limitations of management of these difficult cases.
Subjects and Methods
We reviewed the medical records of all patients with prosthetic valve endocarditis at eight universityaffiliated hospitals in four cities: Columbia, Mo. for 1976-1981; Portland, Ore. for [1981] [1982] [1983] [1984] [1985] [1986] ; San Antonio, Tex. for [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] ; and Minneapolis, Minn, for [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] . Discharge diagnostic codes and consultation logs of the infectious diseases services were used to identify the patients. Diagnosis was based on standard criteria 1 : a febrile illness with a new cardiac murmur and/or cutaneous evidence of microembolization, documentation of at least two blood cultures positive for the same organism, and the lack of any reasonable alternative source of infection. In the absence of diagnostic blood cultures, the observation of typical pathologic lesions at surgery or autopsy was required. In one case unequivocal evidence of rickettsial infection was obtained by serologic testing. Approximately half of the initially identified patients met these criteria and were included in our analysis. The most frequent cause for case rejection was the presence of an alternative source of infection.
The neurologic complications we assessed were embolic stroke and brain hemorrhage. Embolic stroke was denned as the sudden occurrence of a focal neurologic deficit or as an abrupt change in mental status or level of consciousness, correlated with an appropriate evolution of focal abnormalities on cranial computed tomograms (CT scans); we assumed that all acute bland infarcts in the setting of prosthetic valve endocarditis were caused by cardiogenic embolism and not by other mechanisms (e.g., coexistent atherosclerosis). Brain hemorrhage had two patterns. Hemorrhagic infarction was defined by CT criteria as irregular and partially confluent areas of increased x-ray attenuation mingled with areas of decreased attenuation. Intracerebral hemorrhage was denned by CT criteria as a rounded and homogeneous area of increased attenuation comprising essentially all of the lesion, usually with a local mass Early, <60 days after valve implantation; late, >60 days after implantation.
effect; any areas of decreased attenuation appeared only as thin regions of edema at the margins of the blood clot. The use of warfarin anticoagulation was determined at the onset and during the course of treatment for endocarditis, paying particular attention to the timing of any neurologic complications. Adequate anticoagulation was defined as a prolongation of the prothrombin time (PT) to 1.5-2.5 times the laboratory control value.
Antimicrobial therapy was reviewed for each patient in relation to the duration of symptoms before the initiation of treatment, the employment of agents known to be effective against the proven organism, and the duration of treatment. Patients received at least 6 weeks of intravenous antimicrobial therapy with agents chosen on the basis of microbial sensitivity, unless valve replacement surgery or death occurred before the end of this period.
Very little follow-up information was available for most patients. We report only the acute management of incidents of prosthetic valve endocarditis. 25 were mitral, and one involved a Hancock tricuspid valve. Ten patients had both aortic and mitral prostheses, but in six it was possible to determine the specific location of the infection (three were aortic and three were mitral) by echocardiography, surgery, or autopsy, leaving four sites of infection uncertain (Table 1) .
Results

We
Eleven valves became infected early (<60 days after implantation) 2 (Table 1) . None had been placed for the treatment of infective endocarditis; nine native valves had been compromised by chronic rheumatic disease, one was replaced because of valvulopathy associated with ankylosing spondylitis, and the other was replaced because of valvulopathy associated with Marfan's syndrome. The remaining 51 valves became infected late, 67 days to 20 years (mean±SD 4.6±4.7 years) after implantation.
Specific microbial organisms were proven in all 62 episodes (Table 2) , 50 by multiple blood cultures, seven by culture of vegetations obtained at valve replacement surgery, two by culture at autopsy, two by a single positive blood culture in conjunction with clinical criteria including stroke, and one by diagnostic serology for Coxiella burnetii.
M-mode and/or two-dimensional echocardiography was performed at least once (and occasionally several times) in 44 cases; usually both techniques were used (Table 3) . We accepted the interpretation of the studies given in the medical records. In 24 cases no echocardiographic abnormalities were detected; the M-mode technique alone was employed in four of these 24 cases. Vegetations were identified in only 11 (8% of the 25 examined mechanical and 47% of the 19 examined bioprosthetic) valves, one of which also showed restricted valve motion. Nine studies demonstrated other abnormalities, including anomalous valve motion, insufficiency, valve dehiscence, perianulus leaking, and thickening of the bioprosthetic valve leaflets. In the 11 episodes of Early, £60 days after valve implantation; late, >60 days after valve implantation; complications, all neurologic complications (embolic stroke and intracerebral hemorrhage).
'One patient simultaneously infected with two organisms. embolic stroke, six echocardiographic examinations were done only after the event; one poststroke study showed vegetations, but results of the other five were completely normal. In the remaining five episodes of embolic stroke, two M-mode and two-dimensional studies (one in a patient with a mechanical and the other in a patient with a bioprosthetic valve) were both negative 1 day before the event; in two no echocardiography was performed, and in only one was there echocardiographic evidence of vegetations when studied 2 weeks before the event. Table 4 lists the many variations of anticoagulation therapy. In 31 of the 37 episodes of mechanical valve endocarditis warfarin was being given at the onset of the infection. However, in only 18 of the 31 was conventionally optimal PT prolongation obtained. In two episodes warfarin therapy was changed to heparin at the time of diagnosis. Warfarin was simply discontinued on admission in four episodes; in two others warfarin anticoagulation was actively reversed, because of the occurrence of stroke in one and hemorrhage in the other. In 19 of the 25 episodes of bioprosthetic valve endocarditis no anticoagulant was being given at the onset. Heparin was given for only 5 days after admission in one patient. Warfarin was being taken at the time of admission in two patients for chronic atrial fibrillation, in one for congestive heart failure, and in one following recent valve replacement. In one patient warfarin was started on admission.
Approximately half of the episodes of endocarditis were treated surgically ( Table 5 ) by replacement of the infected valve after 2-180 (mean 35) days of antimicrobial therapy. Surgery was undertaken for hemodynamic indications (insufficiency with congestive heart failure, perivalvular leak, valve rupture) in all instances but one, in which avoiding embolization from Coxiella vegetations was the primary rationale. 12 The frequency of neurologic complications (28%, 9 of 32) in episodes treated medically was similar to that in those treated surgically (23%, seven of 30; 2 =0.08, difference not significant).
Overall mortality was 31% (19 of 61), with no differences with respect to management (medical: 34%, 11 of 32; surgical: 26%, eight of 30) or valve type (mechanical: 30%, 11 of 37; bioprosthetic: 32%, eight of 25) ( Table 5 ). In two patients with brain hemorrhage, but in none with bland infarction, the neurologic complication was the direct cause of death.
Neurologic complications occurred in 30% of the cases of mechanical and in 24% of the cases of bioprosthetic valve endocarditis, for an overall rate of 28% (Table 6 ). The overall rate of embolic stroke was 18% and that of brain hemorrhage was 10%. The risk of ischemic stroke (including hemorrhagic transformation) was 22% for patients with mechanical valves (57% were adequately anticoagulated) and 12% for those with bioprosthetic valves (20% were adequately anticoagulated) (* 2 =0.78, difference not significant). The occurrence of embolic and hemorrhagic stroke was not significantly related to valve type (Table 6 ) or infection site (data not shown). In all patients with neurologic complications anticoagulant therapy was effectively unchanged during the course of the acute illness. Therapeutic or subtherapeutic conditions existed both at admission and at the time of the stroke (data not shown). For nonanticoagulated patients (those receiving no warfarin or with subtherapeutic PTs) the rate of neurologic complications was 25% in those with mechanical and 14% in those with bioprosthetic valves; in adequately anticoagulated patients the rates were 33% and 40%, respectively ( Table 6 ). The differences in stroke rates by valve type related to anticoagulation were nonsignificant.
The timing of stroke events was of particular interest. Three occurred on the day of admission, constituting the presenting problem. Four strokes developed <3 days after admission; all were in patients with mechanical valves, three with subtherapeutic and the other with an excessive PT value. Four other strokes occurred >3 days after admission. Only one patient suffered a second embolic stroke identified during life, which occurred in the context of a very complicated terminal course.
Although we made no systematic study of the specific antimicrobial agents used to treat these patients, the establishment of drug treatment appeared to correlate with a reduced stroke occurrence. Table 7 shows the daily stroke risk before and after the establishment of effective antimicrobial treatment for patients with Staphylococcus aureus and 5. epidermidis infections of mechanical valves.
Six patients had brain hemorrhages (Table 6 ). Three were primary hematomas, with no preceding clinical stroke syndrome; two of these patients were receiving anticoagulants at the time of the hemorrhage, but one had a subtherapeutic PT. Two patients had secondary hemorrhages occurring in the setting of anticoagulation after embolic stroke; both had a PT within the therapeutic range at the time of the hemorrhage. One hemorrhage occurred 2 days after an ipsilateral stroke, and CT showed a large hemorrhagic infarct in the area of previous ischemia. The second patient had an intracerebral hemorrhage on the contralateral side 19 days after the initial stroke. Overall, the risk of bleeding was 12% (three of 26) for adequately anticoagulated patients and 9% (three of 36; X 2 =0.25,-difference not significant) for those not Stroke risk 5. epidermidis Before, before effective antimicrobial treatment; after, days of antibiotic treatment (42 days for patients treated medically, number of days to operation for patients treated surgically); stroke risk, number of strokes during risk period divided by number of patient-days at risk.
•Died on day 3. receiving warfarin or with subtherapeutic PTs (Table  6 ). There was no significant difference in the risk of hemorrhage for those with (12%) and without (8%) adequate anticoagulation (# 2 =0.25), nor were there significant differences in the risks for different valve types.
Noncerebral systemic embolic events (including involvement of the limbs and viscera) were recognized in five patients (Table 6 ). Only one of these five also had an embolic stroke.
Discussion
This review presents the largest group of patients with infected prosthetic valves in which the specific details of neurologic morbidity is addressed, increasing the aggregate of such patients in the literature to 2382,3,5,13,14 ( Table 8 ). The 31% overall mortality of our group (Table 5 ) appears low compared with the older literature but is comparable to that in more recent reports. 14 -16 Particularly unexpected is the mortality rate in our early-infected group (Table 2) , 18% being conspicuously lower than the 75% usually quoted. 17 The rate of neurologic complications in our group is relatively low at 28% (Table 6 ) but follows a trend found in other recent studies. 16 The infecting organisms in our series (Table 2) were typical of those reported in the literature.
1 " 317 5. epidermidis was the most prevalent microbial species, occurring in 26% of our patients and surprisingly common in those with late-onset infections.
Infection with S. epidermidis carried disproportionately high rates of stroke (44%) and death (44%), exceeding the risks with both 5. aureus and Gramnegative organisms. Three such illnesses occurred <60 days after valve implantation, and perioperative infection is a reasonable explanation. Seven more patients became ill later during the year after valve replacement, and three of the remaining six were infected > 10 years after surgery. The mechanism of these later infections by an organism of putatively low virulence is not easily explained. 18 These were aggressive infections. Stroke often occurred early and was the presenting clinical problem in three cases. All five patients requiring valve replacement died, and another died of uncontrolled sepsis. In our patients, S. epidermidis was not at all the "nonvirulent" organism it appears to be in native valve endocarditis. 19 Conversely, the outcome of our patients with 5. aureus infections was relatively benign. Their 33% mortality rate was notably lower than the 83% in cases reported previously (Table 9) . Likewise, our patients with streptococcal infections fared better than those in earlier studies.
Our overall rates of embolic stroke (18%, Table 6 ) and mortality (32%, Table 5 ) are similar to those of recent reports of native valve endocarditis. 16 Compared with similar studies (Table 8) , our data are remarkable only for the low stroke rate in nonanticoagulated patients with mechanical valves. 18 Our data lead us to doubt the value of warfarin anticoagulation in reducing the risk of embolism during the acute period of prosthetic valve endocarditis. For our primary analysis we focused our attention on patients with adequate anticoagulation at the time of diagnosis, who suffered most of the embolic stroke events. We also examined the outcome of the 11 patients with PTs 1.1-1.4 times control 23 initially assigned to the nonanticoagulated group (Table 6 ). The 10 inadequately anticoagulated patients with mechanical valves suffered all four neurologic complications (three strokes and one hemorrhage) of the entire nonanticoagulated group. Thus, for neither intensity of anticoagulation could we find a reduced rate of stroke. However, viewed within the context of the aggregate experience in recent years (Table 8) , the evidence favors the use of anticoagulation for patients with mechanical prostheses.
Warfarin therapy and anticoagulation intensity could not be causally implicated in our five patients with brain hemorrhage (Table 6 ); 9% of those without and 12% of those with adequate anticoagulation suffered hemorrhagic deterioration. Brain hemorrhage in patients with endocarditis results from one of three mechanisms: acute pyogenic arteritis during uncontrolled infection, hemorrhagic transformation of embolic infarcts, or rupture of dilated mycotic aneurysms. 24 The third mechanism is generally considered to be a rare complication 16 - 24 and was not observed in our study. When continuing established anticoagulation therapy in patients with infective endocarditis, the risk of hemorrhage is low (in our series three of 26 cases, 12%) unless prior central nervous system embolism has occurred. The most important observation of our study, consistent with some previous reports, 1619 is the timing of stroke events and their relation to antimicrobial treatment. Most emboli occur in the setting of uncontrolled infection, and the initiation of antimicrobial treatment is temporally associated with a sharp reduction in the number of embolic events. This may be in part a fortuitous association due to the recognition of stroke as a presenting feature of endocarditis. Following this reasoning, when emboli occur or recur later during hospitalization, incomplete antimicrobial control of the infection should be considered. Whether surgery should be undertaken at that point cannot be resolved from our data. Surgery is probably not justifiable on the basis of a single embolic stroke 25 -26 because of the low risk of recurrence. 16 
